Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

Hims & Hers (HIMS) is down -17.7%, or -$4.88 to $22.72. Published first on TheFly – the ultimate source for real-time, ...

Amazon (AMZN) has been steadily expanding into healthcare, and now it’s setting its sights on telehealth companies like Hims ...

BofA lowered its rating of Hims & Hers (HIMS) to underperform from buy, citing Amazon’s (AMZN) push into the hair loss and ...

Shares of Hims & Hers ($HIMS) plummeted nearly 15% on Thursday after Amazon.com, Inc. ($AMZN) launched its new Amazon One ...

Amazon One Medical is expanding its telehealth services with the launch of upfront and low-cost treatment plans and ...

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...

FDA’s requirement for truthful, balanced risk and benefit information applies to drugmakers, leaving a loophole for both ...

Hims & Hers (HIMS) fell 17% Thursday after Amazon (AMZN) announced it was launching an expanded pay-per-visit telehealth ...

Amazon announced Prime members can access new upfront pricing to treat five common conditions like erectile disfunction and ...

The tech giant said it would offer upfront, monthly pricing for customers seeking consultations and medications for five ...

In response to the FDA’s shortage decision, Hims & Hers is launching a new GLP-1 tracker, allowing patients to self-identify, provide ...